Request Demo
Last update 24 May 2025
IBR-733
Last update 24 May 2025
Overview
Basic Info
Drug Type CAR-NK |
Synonyms Anti-CLL1/CD33 CAR T Cell(Guangzhou Bio-gene Technology), CLL1/CD33 CAR-T(Guangzhou Bio-gene Technology), IBR733 |
Target |
Action modulators |
Mechanism CD33 modulators(Myeloid cell surface antigen CD33 modulators), CLL-1 modulators(C-Type lectin domain family 12 member A modulators), Natural killer cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
5
Clinical Trials associated with IBR-733NCT06234904
An Open-label, Multi-center, Phase I Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of IBR733 Cell Injection in Acute Myeloid Leukemia
NCT05943314
Safety and Efficacy of Anti-CLL1 /+CD33 CAR T Cells in Refractory/Recurrent Acute Myeloid Leukemia: a Single-arm, Non-blind Clinical Study
ChiCTR2200061284
A Single-arm, Open-label, Single-center Clinical Study: Safety, Tolerability and Preliminary Efficacy of Autologous Anti-CLL1/CLL1+CD33 CAR-T in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in Children
100 Clinical Results associated with IBR-733
Login to view more data
100 Translational Medicine associated with IBR-733
Login to view more data
100 Patents (Medical) associated with IBR-733
Login to view more data
100 Deals associated with IBR-733
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Myeloid Leukemia | Phase 1 | China | 02 Apr 2024 | |
| Refractory acute myeloid leukemia | Clinical | China | 12 Jul 2023 | |
| Relapsing acute myeloid leukemia | Clinical | China | 12 Jul 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free